Related Experiment Video
Updated: May 3, 2026

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
112.5K
Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation
Cell Death and Differentiation
|February 11, 2014
Summary
The Wnt signaling pathway enhances osteogenic differentiation by increasing TAZ protein stability and nuclear localization. This process involves dephosphorylation of TAZ by PP1A, highlighting a link between Wnt signaling and the Hippo pathway.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- TAZ is a key transcriptional modulator regulating cell proliferation, differentiation, and stem cell self-renewal.
- TAZ activity is influenced by Hippo, GPCR, and Wnt signaling pathways, but its precise activation mechanisms remain unclear.
Purpose of the Study:
- To investigate the role of canonical Wnt signaling in regulating TAZ activity during osteogenic differentiation.
- To elucidate the molecular mechanisms by which Wnt signaling controls TAZ activation and subsequent osteoblast differentiation.
Main Methods:
- Utilized Wnt3a stimulation and GSK3β inhibition to study TAZ regulation.
- Employed siRNA to deplete PP1A and assess its impact on TAZ stabilization.
- Analyzed TAZ expression, dephosphorylation, nuclear localization, and its role in osteogenic differentiation.
Main Results:
- Wnt3a stimulation increased TAZ expression and promoted its dephosphorylation, leading to stabilization and nuclear translocation.
- PP1A was identified as the phosphatase responsible for TAZ dephosphorylation; its depletion inhibited Wnt3a-induced TAZ stabilization.
- Wnt3a-induced TAZ activation was essential for osteoblastic differentiation, as TAZ depletion reduced Wnt3a-mediated osteogenesis.
Conclusions:
- TAZ mediates Wnt3a-stimulated osteogenic differentiation through the PP1A phosphatase.
- These findings reveal that Wnt signaling regulates the Hippo pathway via TAZ, impacting osteoblast differentiation.
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
6.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K
Non-Canonical Wnt Signaling Pathways
1.5K
1.5K
Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Canonical Wnt Signaling Pathway
1.9K
1.9K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K

